Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.

Journal of Korean Medical Science
Ji Young LeeJae Hoon Song

Abstract

This study was undertaken to evaluate the in vitro activities of arbekacin-based combination regimens against vancomycin hetero-intermediate Staphylococcus aureus (hetero-VISA). Combinations of arbekacin with vancomycin, rifampin, ampicillin-sulbactam, teicoplanin, or quinupristin-dalfopristin against seven hetero-VISA strains and two methicillin-resistant S. aureus strains were evaluated by the time-kill assay. The combinations of arbekacin with vancomycin, teicoplanin, or ampicillin-sulbactam showed the synergistic interaction against hetero-VISA strains. Data suggest that these arbekacin-based combination regimens may be useful candidates for treatment options of hetero-VISA infections.

References

Jun 1, 1995·The Journal of Antimicrobial Chemotherapy·J M Hamilton-Miller, S Shah
May 1, 1996·The Journal of Antibiotics·K HottaS Kondo
Apr 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L R PetersonH A Nordbrock
Jul 1, 1997·The Journal of Antimicrobial Chemotherapy·K HiramatsuF C Tenover
Mar 11, 1998·Lancet·R A HoweA P MacGowan
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S S WongK Y Yuen
Oct 4, 2000·Journal of Clinical Microbiology·M N KimK Hiramatsu
Mar 2, 2002·The Lancet Infectious Diseases·K Hiramatsu
Jul 27, 2002·Annual Review of Microbiology·Timothy R Walsh, Robin A Howe
Apr 4, 2003·The New England Journal of Medicine·Soju ChangUNKNOWN Vancomycin-Resistant Staphylococcus aureus Investigative Team
Jun 13, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy S NaimiRuth Lynfield
Jun 28, 2003·Pediatrics International : Official Journal of the Japan Pediatric Society·Keiji Suzuki
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Fred C TenoverBülent Bozdogan
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cynthia J WhitenerScott K Fridkin
Oct 12, 2004·Diagnostic Microbiology and Infectious Disease·Kerry L LaPlante, Michael J Rybak

❮ Previous
Next ❯

Citations

Aug 18, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Dayang Fredalina Basri, Radhiah Khairon
Aug 17, 2011·International Journal of Molecular Sciences·Olayinka AiyegoroAnthony Okoh
Feb 13, 2013·Archives of Oral Biology·Kyung-Yeol LeeJeong-Dan Cha
May 2, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Jeong-Dan ChaJeong Hye Park
Apr 23, 2016·Infection & chemotherapy·Jae Hoon Lee, Chang-Seop Lee
Dec 21, 2007·The Korean journal of laboratory medicine·Jonghan LeeYunsop Chong

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.